C. Randal Mills

President & CEO at Aziyo Biologics

Dr. Randy Mills, Ph.D., co-founder of Aziyo Biologics, has served as a member of Aziyo’s board of directors since November 2015. Randy and Kevin Rakin started Aziyo with the vision to build a regenerative medicine company to improve the lives of patients by developing a pipeline of cutting-edge biosurgical products.

Dr. Mills is an internationally recognized expert in regenerative medicine who has led pioneering biotechnology organizations that have created more than $1 billion in shareholder value for investors. As CEO of Osiris Therapeutics (Nasdaq: OSIR), he commercialized five cell-therapy products responsible for $1.5 billion in sales and led the company through an IPO that increased shareholder value 41-fold. Osiris was eventually sold to Smith and Nephew for $660 million. Dr. Mills was also a co-founder and officer of Regeneration Technologies (Nasdaq: RTIX), where he led operations, R&D, regulatory, and business development through its successful IPO.

Location

San Diego, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Aziyo Biologics

Aziyo Biologics is a fully integrated, commercially oriented regenerative medicine company. Since its founding in 2015, the Company has expanded through acquisitions and strategic partnerships, creating a high-growth commercial entity. Its proprietary products are used in orthopedic, cardiovascular, and other medical specialties.


Industries

Employees

51-200

Links